Tag: Anvisa

• Monday, April 26th 2021 - 08:41 UTC

  Anvisa expected to decide Monday on fate of Sputnik V vaccine in Brazil

  

  Brazil's National Health Surveillance Agency (Anvisa) will evaluate this coming week the feasibility of importing the Russian-manufactured Sputnik V vaccine against covid-19.

• Wednesday, April 21st 2021 - 09:35 UTC

  Anvisa asks STF for more time to decide on the use of Sputnik V in Brazil

  

  While Argentina has already started trials to produce the Russian Sputnik V vaccine against covid-19, Brazil’s National Health Surveillance Agency (Anvisa) has filed a petition before the Federal Supreme Court (STF) for additional time to evaluate a registration request for the very same immunization shot.

• Tuesday, April 20th 2021 - 10:45 UTC

  Brazil's Anvisa green-lights studies of new Chinese covid-19 vaccine

  

  Brazil's National Health Surveillance Agency (Anvisa) has given the green light to clinical trials on volunteers of a potential anti-Covid-19 vaccine produced by the Chinese laboratory Sichuan Clover Biopharmaceuticals, it was announced.

• Saturday, April 10th 2021 - 10:58 UTC

  Brazil's Anvisa to check Russian Sputnik V manufacturing plant as need for vaccines soars

  

  Brazil's National Health Surveillance Agency (Anvisa) will be sending a delegation to Russia next week to conduct an onsite review of the facilities where the Sputnik V vaccine is manufactured, it was announced Friday.

• Friday, January 15th 2021 - 09:30 UTC

  Delays in launching an inoculation program in Brazil, threatens the economic recovery

  

  The risks to an expected economy recovery in Brazil during 2021 are increasing as delays in rolling out a vaccine program against coronavirus continues to be delayed, according to Moody's rating agency.

• Monday, January 4th 2021 - 05:36 UTC

  Brazil health regulator approves import of 2 million doses of AstraZeneca vaccine

  

  Brazil's health regulator Anvisa said over the weekend it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, although the jab is not yet approved for use in the country.

• Wednesday, December 16th 2020 - 08:51 UTC

  Brazil's health regulator ANVISA considers Chinese Covid-19 vaccine process non transparent

  

  Brazil’s health regulator Anvisa said China’s health authorities are not transparent in their authorization of COVID-19 vaccines for emergency use, a statement that may further inflame political tension in the country.

• Thursday, December 3rd 2020 - 09:52 UTC

  Brazil's health regulator open to approving Covid-19 vaccines for emergency use

  

  Brazil’s health regulator Anvisa said on Wednesday it was open to approving COVID-19 vaccines for emergency use and outlined the requirements for companies looking to do so.

• Thursday, November 12th 2020 - 09:42 UTC

  Bolsonaro's clash with Sao Paulo governor over the Chinese vaccine tainted with politics

  

  Brazil’s national health regulator allowed clinical trials of a Chinese-developed Covid-19 vaccine to resume on Wednesday, two days after suspending them in what critics called a decision tainted by politics.

• Wednesday, November 4th 2020 - 08:46 UTC

  Johnson & Johnson resumes clinical trials of the Covid-19 vaccine in Brazil

  

  Brazilian health regulator Anvisa has authorized the resumption of a clinical trial of Johnson & Johnson's experimental COVID-19 vaccine, according to a statement from the government agency on Tuesday.